ClinConnect ClinConnect Logo
Search / Trial NCT05616702

Effectiveness of Pressure Biofeedback Therapy and Progressive Muscle Relaxation Technique in Improving Pain and Disability Among Patients With Non-Specific Low Back Pain

Launched by DOW UNIVERSITY OF HEALTH SCIENCES · Nov 7, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pressure Biofeedback Therapy Progressive Muscles Relaxation Technique Chronic Non Specific Low Back Pain Chronic Low Back Pain Non Specific Back Pain

ClinConnect Summary

This clinical trial is studying two different treatments for people suffering from non-specific low back pain, which is a common issue affecting many individuals. The trial aims to see how effective a combination of pressure biofeedback therapy—this helps support the lower back by adjusting pressure in the abdomen—and progressive muscle relaxation techniques—designed to reduce tension and improve flexibility—can be in helping patients manage their pain and improve their mobility. The trial is for adults aged 30 to 50 who have been experiencing low back pain for more than three months.

To participate, individuals should be diagnosed with chronic low back pain but should not have had any surgeries on their spine or other serious spine-related conditions. Those who join the trial can expect to receive either the combined treatment or just the muscle relaxation techniques to see which works better for reducing pain and improving their daily activities. This study is actively recruiting participants, and it provides an opportunity for those with chronic back pain to explore new ways to find relief.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosed and referred patients with non-specific low back pain for more than 3 months
  • 30 to 50 years
  • Both genders
  • Exclusion Criteria:
  • Any surgical history of lumbar spine
  • Infections of the spine, malignancy
  • Disc protrusion
  • History of spinal fractures

About Dow University Of Health Sciences

Dow University of Health Sciences (DUHS) is a premier educational and research institution based in Karachi, Pakistan, dedicated to advancing healthcare through innovative research and clinical excellence. As a clinical trial sponsor, DUHS integrates cutting-edge scientific inquiry with practical applications, fostering a collaborative environment that promotes the development of new treatments and therapies. The institution is committed to upholding the highest ethical standards in research, ensuring participant safety, and contributing to the global body of medical knowledge. With a focus on interdisciplinary collaboration and community health impact, DUHS plays a pivotal role in enhancing the quality of healthcare both locally and internationally.

Locations

Karachi, Sindh, Pakistan

Patients applied

0 patients applied

Trial Officials

Farhan I Khan, Ph.D, MBA, MSc.PT, DPT

Study Director

Dow University of Health Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials